Based on bioactivity predictions using PASS Online, 4-propylbiphenyl acts as a glucan endo-1,6-beta-glucosidase inhibitor, α-amylase inhibitor, diabetic neuropathy treatment, and insulin promoter. Here, INS is linked to diabetic neuropathy.